Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRemoved the 'Multiple myeloma' condition label and the related topics section, including the 'MedlinePlus Genetics' link.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded core topics 'Multiple myeloma' and 'MedlinePlus Genetics' and updated the page to Revision v3.4.2. Removed the government-funding lapse notice and the previous revision tag v3.4.1.SummaryDifference0.3%

- Check41 days agoChange DetectedNotice about lapse in government funding and a version revision were added, while a non-critical topic (“Multiple myeloma”) was removed from related content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check48 days agoChange DetectedThe author list for the DREAMM-2 publication has been removed. The page now includes a Show glossary option and new update metadata such as Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now includes a 'Multiple myeloma' topic and a MedlinePlus Genetics related topics link, which are navigational/contextual additions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.